Macalma, Whadz-al P.

HRN: 24-07-65  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/10/2023
CEFTRIAXONE 1G (VIAL)
11/10/2023
11/16/2023
IV
800mg
OD
AGE With Severe Dehydration
Waiting Final Action 
11/15/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/15/2023
11/22/2023
IV
450
Q6H
AGE
Waiting Final Action 
11/15/2023
CEFTRIAXONE 1G (VIAL)
11/15/2023
11/19/2023
IV
900mg
Q24h
PCAP C
Waiting Final Action 
12/20/2023
AMPICILLIN 500MG (VIAL)
12/20/2023
12/27/2023
IV
420mg
Q6H
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: